alexa The Novel Excipient, Dodecyl-2-N, N-dimethylaminopropionate Hydrochloride (DDAIP-HCl) Improves the Flux of Minoxidil in Human Skin

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Novel Excipient, Dodecyl-2-N, N-dimethylaminopropionate Hydrochloride (DDAIP-HCl) Improves the Flux of Minoxidil in Human Skin

Minoxidil, the pyrimidine derivative (2,4-diamino-6- piperidinopyrimidine-3-oxide), is the only Food and Drug Administration-approved topical treatment with proven efficacy for the treatment of male pattern hair loss (MPHL) or Androgenetic alopecia (AGA). Androgenetic alopecia is hereditary and characterized by the shortening of hair follicles in the frontal and parietal scalp

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords